A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

被引：0
|
作者：
Mark E Robson
Pierre O Chappuis
Jaya Satagopan
Nora Wong
Jeff Boyd
John R Goffin
Clifford Hudis
David Roberge
Larry Norton
Louis R Bégin
Kenneth Offit
William D Foulkes
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Medicine
[2] Cancer Prevention Centre,Research Institute of McGill University Health Centre
[3] McGill University,Department of Epidemiology/Biostatistics
[4] Memorial Sloan-Kettering Cancer Center,Cancer Prevention Centre, Sir Mortimer B Davis
[5] McGill University,Jewish General Hospital
[6] Memorial Sloan-Kettering Cancer Center,Department of Surgery
[7] McGill University,Department of Oncology
[8] McGill University,Department of Pathology
[9] McGill University,Program in Cancer Genetics, Departments of Oncology and Human Genetics
[10] University Hospitals of Geneva,Divisions of Oncology and Medical Genetics
[11] Hôpital du Sacré-Coeur de Montréal,Division of Hematology/Oncology, Department of Medicine
[12] Tufts University,undefined
[13] Tufts University-New England Medical Center,undefined
来源：
Breast Cancer Research | / 6卷
关键词：
adjuvant therapy; breast cancer; contralateral; ipsilateral; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [32] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Joanne Kotsopoulos
    Jacek Gronwald
    Tomasz Huzarski
    Amber Aeilts
    Susan Randall Armel
    Beth Karlan
    Christian F. Singer
    Andrea Eisen
    Nadine Tung
    Olufunmilayo Olopade
    Louise Bordeleau
    Charis Eng
    William D. Foulkes
    Susan L. Neuhausen
    Carey A. Cullinane
    Tuya Pal
    Robert Fruscio
    Jan Lubinski
    Kelly Metcalfe
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
  • [33] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly Metcalfe
    Henry T. Lynch
    Parviz Ghadirian
    Nadine Tung
    Charmaine Kim-Sing
    Olufunmilayo I. Olopade
    Susan Domchek
    Andrea Eisen
    William D. Foulkes
    Barry Rosen
    Danny Vesprini
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2011, 127 : 287 - 296
  • [34] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Salmena, Leonardo
    Lynch, Henry T.
    Kim-Sing, Charmaine
    Foulkes, William D.
    Ghadirian, Parviz
    Neuhausen, Susan L.
    Demsky, Rochelle
    Tung, Nadine
    Ainsworth, Peter
    Senter, Leigha
    Eisen, Andrea
    Eng, Charis
    Singer, Christian
    Ginsburg, Ophira
    Blum, Joanne
    Huzarski, Tomasz
    Poll, Aletta
    Sun, Ping
    Narod, Steven A.
    BREAST CANCER RESEARCH, 2012, 14 (02):
  • [35] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Ahmed, M.
    Lalloo, F.
    Howell, A.
    Evans, D. G.
    BREAST CANCER RESEARCH, 2010, 12 : S6 - S6
  • [36] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, Kelly
    Lynch, Henry T.
    Ghadirian, Parviz
    Tung, Nadine
    Kim-Sing, Charmaine
    Olopade, Olufunmilayo I.
    Domchek, Susan
    Eisen, Andrea
    Foulkes, William D.
    Rosen, Barry
    Vesprini, Danny
    Sun, Ping
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 287 - 296
  • [37] Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Graeser, Monika K.
    Engel, Christoph
    Rhiem, Kerstin
    Gadzicki, Dorothea
    Bick, Ulrich
    Kast, Karin
    Froster, Ursula G.
    Schlehe, Bettina
    Bechtold, Astrid
    Arnold, Norbert
    Preisler-Adams, Sabine
    Nestle-Kraemling, Carolin
    Zaino, Mohammad
    Loeffler, Markus
    Kiechle, Marion
    Meindl, Alfons
    Varga, Dominic
    Schmutzler, Rita K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5887 - 5892
  • [38] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K.
    Gershman, S.
    Lynch, H. T.
    Ghadirian, P.
    Tung, N.
    Kim-Sing, C.
    Olopade, O. I.
    Domchek, S.
    McLennan, J.
    Eisen, A.
    Foulkes, W. D.
    Rosen, B.
    Sun, P.
    Narod, S. A.
    BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1384 - 1392
  • [39] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Rebbeck, Timothy R.
    Domchek, Susan M.
    BREAST CANCER RESEARCH, 2008, 10 (04)
  • [40] BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
    Rosenberg, Shoshana M.
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Gelber, Shari
    Schapira, Lidia
    Come, Steven
    Borges, Virginia F.
    Larsen, Bryce
    Garber, Judy E.
    Partridge, Ann H.
    JAMA ONCOLOGY, 2016, 2 (06) : 730 - 736
12345